Premium
Alpha‐fetoprotein and γ‐glutamyltranspeptidase in mice. Effect of raf gene
Author(s) -
Jalanko Hannu
Publication year - 1979
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.2910240403
Subject(s) - carbon tetrachloride , endocrinology , medicine , alpha fetoprotein , basal (medicine) , ratón , fetus , ccl4 , chemistry , biology , hepatocellular carcinoma , pregnancy , genetics , organic chemistry , insulin
The regulation of the high physiological level of serum alpha‐fetoprotein (AFP) in BALB/c/J mice was studied. Serum AFP concentration in 7‐ to 12‐week‐old BALB/c/J mice varied from 460 ng/ml up to 2,790 ng/ml and in other strains tested from 10 ng/ml to 400 ng/ml. In contrast to the difference in serum AFP level, activity of the fetal enzyme γ‐glutamyltranspeptidase (GGT) in the liver of BALB/c/J mice was similar to that found in other mice. In all newborn mice, the initially high GGT activity decreased almost 100‐fold during the first 10 days. The serum AFP concentration stayed relatively stable during this period. AFP decreased to the adult level between the 10th and 30th days. Partial hepatectomy and administration of carbon tetrachloride increased the serum AFP level in all mice. The elevation of AFP was 10 times higher in BALB/c/J mice than in mice with low basal AFP level. A slightly elevated GGT activity in the liver was observed in only 10 out of 40 mice after carbon tetrachloride treatment, but none of the mice after partial hepatectomy showed an elevation. These results suggest that the gene (“Raf” gene) controlling the reduced decrease of serum AFP level in young BALB/c/J mice enhances the “turning on” of production of AFP in the regenerating liver. This gene does not, however, control the expression of the other carcinofetal liver marker, GGT.